Clinical Trial

The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 6, 2024 (before its estimated September 15, 2025 completion). Its status may not reflect the trial's current state.
Summary
In patients initiating Semaglutide for weight management, the objective is to compare the effect of the Mediterranean diet and the high protein/low carbohydrate (HP/LC) diet CV parameters, namely arterial stiffness, measured by carotid-femoral pulse wave velocity (cfPWV), and visceral adipose tissue, in addition to other metabolic indicators.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-07-26; most recent amendment 2024-08-03.
Trial Details
NCT Number NCT04990024
Lead Sponsor American University of Beirut Medical Center
Conditions Obesity, Weight Loss
Enrollment 60 participants
Start Date 2021-07-01
Primary Completion 2025-09-15 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2024-08-06